Tryton Medical, Inc. Announces Clinical Presentations at TCT Conference in San Francisco

Published: Nov 02, 2011

DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced activities highlighting the latest experience with the TRYTON Side Branch Stent at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2011 conference taking place Nov. 7-11 in San Francisco.

Back to news